Adenocarcinoma  >>  Mekinist (trametinib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mekinist (trametinib) / Novartis, BeiGene
NCT01438554: Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark AACR-NCI-EORTC 2013
Oct 2013 - Oct 2013: AACR-NCI-EORTC 2013
Checkmark P1 data-ASCO
More
Completed
1
89
US
Pazopanib, Votrient, GSK1120212, Trametinib, Mekinist
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Comprehensive Cancer Network, Novartis
Solid Tumors, Thyroid Cancer, Soft-tissue Sarcoma, Cholangiocarcinoma
04/16
08/18

Download Options